Advertisement

Establishment of resveratrol and its derivatives as neuroprotectant against monocrotophos-induced alteration in NIPBL and POU4F1 protein through molecular docking studies

  • Ruchi Yadav
  • Prachi SrivastavaEmail author
Research Article
  • 49 Downloads

Abstract

Monocrotophos (MCP) is a broad spectrum organophosphorus insecticide, which is widely used as foliar spray to the different important crops. MCP may reach the soil and the aquatic environment directly or indirectly during and after the application, which leads to the different environmental issues. MCP is found to be associated with neurotoxicity and its toxic effects have been monitored during different stages of neuronal development. Identification of gene expression in MCP-induced neurotoxicity during neuronal developmental stage is a major area of genomic research interest. In accordance with this identification, screening of potential neuroprotective, natural resources are also required as a preventive aspects by targeting the impaired genes. In this current course of work, microarray experiment has been used to identify genes that were expressed in monocrotophos (MCP)-induced mesenchymal stem cells (MSC) and also the neuroprotectant activity of RV on MCP-exposed MSCs. Microarray experiment data have been deposited in NCBI’s Gene Expression Omnibus database and are accessible through GEO Series accession number GSE121261. In this paper, we have discussed two important genes NIPBL (nipped-B-like protein) and POU4F1 (POU domain, class 4, transcription factor 1). These genes were found to be significantly expressed in MCP-exposed MSC and show minimum expression in presence of RV. Homology modelling and docking study was done to identify the interaction and binding affinity of resveratrol and its derivatives with NIPBL and POU4F1 protein. Docking analysis shows that RV and its derivatives have strong interaction with NIPBL and POU4F1 protein hence proves the significance of resveratrol as potential neuroprotectant. This paper highlights the hazardous impact of MCP on neuronal development disorders and repairing potentiality of RV and its derivatives on altered genes involved in neuronal diseases.

Graphical Abstract

Keywords

Monocrotophos Neurodevelopment Resveratrol NIPBL POU4F1 Docking Homology modelling 

Notes

Supplementary material

11356_2019_6806_MOESM1_ESM.xlt (98 kb)
ESM 1 (XLT 98 kb)

References

  1. Alahakoon C, Dassanayake TL, Gawarammana IB, Sedgwick EM et al (2018) Prediction of organophosphorus insecticide-induced intermediate syndrome with stimulated concentric needle single fibre electromyography. PLoS One 13:e0203596CrossRefGoogle Scholar
  2. Andersen B, Rosenfeld MG (2001) POU domain factors in the neuroendocrine system: lessons from developmental biology provide insights into human disease. Endocr Rev 22:2–35Google Scholar
  3. Bergantin LB, Caricati-Neto A (2016) Challenges for the pharmacological treatment of neurological and psychiatric disorders: Implications of the Ca2+/cAMP intracellular signalling interaction. Eur J Pharmacol 788:255–260CrossRefGoogle Scholar
  4. Bernardes MFF, Pazin M, Pereira LC, Dorta DJ (2015) Impact of pesticides on environmental and human health. In: Toxicology Studies-Cells, Drugs and Environment. InTech, Ana Cristina Andreazza and Gustavo Scola, IntechOpen,  https://doi.org/10.5772/59710.Google Scholar
  5. Bhuvanendran S, Hanapi NA, Ahemad N, Othman I, Yusof SR, Shaikh MF (2019) Embelin, a Potent Molecule for Alzheimer's Disease: A Proof of Concept From Blood-Brain Barrier Permeability, Acetylcholinesterase Inhibition and Molecular Docking Studies. Frontiers in neuroscience 13:495.  https://doi.org/10.3389/fnins.2019.00495 
  6. Chen C, Meng Q, Xia Y, Ding C et al (2018) The transcription factor POU3F2 regulates a gene coexpression network in brain tissue from patients with psychiatric disorders. Sci Transl Med 10:eaat8178CrossRefGoogle Scholar
  7. Cook AL, Sturm RA (2008) POU domain transcription factors: BRN2 as a regulator of melanocytic growth and tumourigenesis. Pigment Cell Melanoma Res 21:611–626CrossRefGoogle Scholar
  8. Dimitri P, Corradini N, Rossi F, Vernì F (2005) The paradox of functional heterochromatin. Bioessays 27:29–41CrossRefGoogle Scholar
  9. Dorsett D (2011) Cohesin: genomic insights into controlling gene transcription and development. Curr Opin Genet Dev 21:199–206CrossRefGoogle Scholar
  10. Eng SR, Gratwick K, Rhee JM et al (2001) Defects in sensory axon growth precede neuronal death in Brn3a-deficient mice. J Neurosci 21:541–549CrossRefGoogle Scholar
  11. Eriksson P (1997) Developmental neurotoxicity of environmental agents in the neonate. Neurotoxicology 18:719–726Google Scholar
  12. Fane ME, Chhabra Y, Smith AG, Sturm RA (2019) BRN 2, a POU erful driver of melanoma phenotype switching and metastasis. Pigment Cell Melanoma Res 32:9–24CrossRefGoogle Scholar
  13. Frasch MG, Schulkin J, Metz GA, Antonelli M (2017) Animal Models of Fetal Programming: Focus on Chronic Maternal Stress During Pregnancy and Neurodevelopment. In: Animal Models for the Study of Human Disease, pp 839–849CrossRefGoogle Scholar
  14. Friesner RA, Murphy RB, Repasky MP et al (2006) Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes. J Med Chem 49:6177–6196CrossRefGoogle Scholar
  15. Fujita Y, Yamashita T (2018) Spatial organization of genome architecture in neuronal development and disease. Neurochem Int 119:49–56CrossRefGoogle Scholar
  16. Grandjean P, Landrigan PJ (2006) Developmental neurotoxicity of industrial chemicals. Lancet 368:2167–2178CrossRefGoogle Scholar
  17. Halgren T (2009) Identifying and characterizing binding sites and assessing druggability. J Chem Inf Model 49:377–389CrossRefGoogle Scholar
  18. He F, Xu H, Qin F, Xu L, Huang J, He X (1998) Intermediate myasthenia syndrome following acute organophosphates poisoning-an analysis of 21 cases. Hum Exp Toxicol 17:40–45Google Scholar
  19. Herr W, Sturm RA, Clerc RG, Corcoran LM, Baltimore D, Sharp PA, Ingraham HA, Rosenfeld MG, Finney M, Ruvkun G (1988) The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. Genes Dev 2:1513–1516CrossRefGoogle Scholar
  20. Jahan S, Kumar D, Singh S, Kumar V, Srivastava A, Pandey A, Pant AB (2018) Resveratrol prevents the cellular damages induced by monocrotophos via PI3K signaling pathway in human cord blood mesenchymal stem cells. Mol Neurobiol 55(11):8278–92. CrossRefGoogle Scholar
  21. Jokanović M (2018) Neurotoxic effects of organophosphorus pesticides and possible association with neurodegenerative diseases in man: A review. Toxicology 410:125–131CrossRefGoogle Scholar
  22. Kazi AI, Oommen A (2012) Monocrotophos induced oxidative damage associates with severe acetylcholinesterase inhibition in rat brain. Neurotoxicology 33:156–161CrossRefGoogle Scholar
  23. Kim S, Thiessen PA, Bolton EE et al (2015) PubChem substance and compound databases. Nucleic Acids Res 44:D1202–D1213CrossRefGoogle Scholar
  24. Kline AD, Krantz ID, Sommer A et al (2007) Cornelia de Lange syndrome: clinical review, diagnostic and scoring systems, and anticipatory guidance. Am J Med Genet A 143:1287–1296CrossRefGoogle Scholar
  25. Knowles MA, Hurst CD (2015) Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat Rev Cancer 15:25CrossRefGoogle Scholar
  26. Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26:283–291CrossRefGoogle Scholar
  27. Latchman DS (1999) POU family transcription factors in the nervous system. J Cell Physiol 179:126–133CrossRefGoogle Scholar
  28. Lorke DE, Petroianu GA (2019) Reversible cholinesterase inhibitors as pretreatment for exposure to organophosphates A review. J Appl Toxicol 39:101–116CrossRefGoogle Scholar
  29. MacCallum WG, Voegtlin C (1909) On the relation of tetany to the parathyroid glands and to calcium metabolism. J Exp Med 11:118–151CrossRefGoogle Scholar
  30. Malik V, Zimmer D, Jauch R (2018) Diversity among POU transcription factors in chromatin recognition and cell fate reprogramming. Cell Mol Life Sci 75:1587–1612CrossRefGoogle Scholar
  31. Mendelssohn H, Paz U (1977) Mass mortality of birds of prey caused by Azodrin, an organophosphorus insecticide. Biol Conserv 11:163–170CrossRefGoogle Scholar
  32. Misulovin Z, Schwartz YB, Li XY, Kahn TG, Gause M, MacArthur S, Fay JC, Eisen MB, Pirrotta V, Biggin MD, Dorsett D (2008) Association of cohesin and Nipped-B with transcriptionally active regions of the Drosophila melanogaster genome. Chromosoma 117:89–102CrossRefGoogle Scholar
  33. Olley G, Ansari M, Bengani H, Grimes GR et al (2018) Publisher Correction: BRD4 interacts with NIPBL and BRD4 is mutated in a Cornelia de Lange-like syndrome. Nat Genet 50:767–767CrossRefGoogle Scholar
  34. Palaniappen V (2013) Current concepts in the management of organophosphorus compound poisoning. Medicine Update. The Association of Physicians of India, Mumbai, pp 427–433Google Scholar
  35. Pickett MA, Dush MK, Nascone Yoder NM (2017) Acetylcholinesterase plays a non-neuronal, non-esterase role in organogenesis. Development 144:2764–2770CrossRefGoogle Scholar
  36. Qian CS, Kaplow M, Lee JK, Grueber WB (2018) Diversity of internal sensory neuron axon projection patterns is controlled by the POU-domain protein Pdm3 in Drosophila larvae. J Neurosci 38:2081–2093CrossRefGoogle Scholar
  37. Rajarajan P, Gil SE, Brennand KJ, Akbarian S (2016) Spatial genome organization and cognition. Nat Rev Neurosci 17:681CrossRefGoogle Scholar
  38. Requena M, Parrón T, Navarro A, García J, Ventura MI, Hernández AF, Alarcón R (2018) Association between environmental exposure to pesticides and epilepsy. Neurotoxicology 68:13–18CrossRefGoogle Scholar
  39. Ryan AK, Rosenfeld MG (1997) POU domain family values: flexibility, partnerships, and developmental codes. Genes Dev 11:1207–1225CrossRefGoogle Scholar
  40. Saiko P, Szakmary A, Jaeger W, Szekeres T (2008) Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutati Res/Rev Mutat Res 658:68–94CrossRefGoogle Scholar
  41. Sastry GM, Adzhigirey M, Day T et al (2013) Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. J Comput Aid Mo Des 27:221–234CrossRefGoogle Scholar
  42. Schrodinger L (2011) Schrodinger software suite. Schrödinger LLC, New York, p 670Google Scholar
  43. Sharma DR, Thapa RB, Manandhar HK et al (2012) Use of pesticides in Nepal and impacts on human health and environment. J Agric Environ 13:67–74CrossRefGoogle Scholar
  44. Smith MD, Ensor EA, Coffin RS, Boxer LM, Latchman DS (1998) Bcl-2 transcription from the proximal P2 promoter is activated in neuronal cells by the Brn-3a POU family transcription factor. J Biol Chem 273:16715–16722CrossRefGoogle Scholar
  45. Srivastava A, Vatsa P, Singh S, Kumar D, Pant AB (2018) Apoptotic Response of Human Mesenchymal Stem Cells against Dose Dependent Exposure to Organophosphate Pesticide-Monocrotophos. J Ecophysiol Occup Health 17:106–113Google Scholar
  46. Studer G, Tauriello G, Bienert S, Waterhouse AM et al (2019) Modeling of Protein Tertiary and Quaternary Structures Based on Evolutionary Information. In: Computational Methods in Protein Evolution. Humana Press, New York, pp 301–316CrossRefGoogle Scholar
  47. Tellone E, Galtieri A, Russo A, Barreca D, Ficarra S (2019) Resveratrol. In: Nonvitamin and nonmineral nutritional supplements. Academic Press, pp 107–110  https://doi.org/10.1016/B978-0-12-812491-8.00014-X CrossRefGoogle Scholar
  48. Thorat K, Pandey S, Chandrashekharappa S, Vavilthota N et al (2018) Prevention of pesticide-induced neuronal dysfunction and mortality with nucleophilic poly-Oxime topical gel. Sci Adv 4:eaau1780CrossRefGoogle Scholar
  49. Veenstra GJC, van der Vliet PC, Destrée OH (1997) POU domain transcription factors in embryonic development. Mol Biol Rep 24:139–155CrossRefGoogle Scholar
  50. Verberk MM (1977) Incipient cholinesterase inhibition in volunteers ingesting monocrotophos or mevinphos for one month. Toxicol Appl Pharmacol 42:345–350CrossRefGoogle Scholar
  51. Wilson C, Tisdell C (2001) Why farmers continue to use pesticides despite environmental, health and sustainability costs. Ecol Econ 39:449–462CrossRefGoogle Scholar
  52. Xavier MD, Urcino ATA, dos Santos GM et al (2018) Vulnerability of rural workers to pesticides. Unimontes Científica 415–22Google Scholar
  53. Yadav R, Srivastava P (2018) Clustering, Pathway Enrichment, and Protein-Protein Interaction Analysis of Gene Expression in Neurodevelopmental Disorders. Adv Pharmacol Sci.  https://doi.org/10.1155/2018/3632159 CrossRefGoogle Scholar
  54. Yadav R et al. (2018) NCBI's Gene Expression Omnibus (GEO Series accession number GSE121261 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE121261)
  55. Yadav R, Deepshikha D, Srivastava P (2017) Homology Modeling and Protein Interaction Map of CHRNA7 Neurogenesis Protein. Ann Neurosci 24:173–179CrossRefGoogle Scholar
  56. Yang CC, Deng JF (2007) Intermediate syndrome following organophosphate insecticide poisoning. J Chin Med Assoc 70:467–472CrossRefGoogle Scholar
  57. Zimmerman G, Soreq H (2006) Termination and beyond: acetylcholinesterase as a modulator of synaptic transmission. Cell Tissue Res 326:655–669CrossRefGoogle Scholar
  58. Zou M, Li S, Klein WH, Xiang M (2012) Brn3a/Pou4f1 regulates dorsal root ganglion sensory neuron specification and axonal projection into the spinal cord. Dev Biol 364:114–127CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Amity Institute of BiotechnologyAmity University Uttar PradeshLucknowIndia

Personalised recommendations